Autres langues

01/08 SMS Pharmaceuticals Limited announces Annual dividend, payable on October 23, 2026
31/07 SMS Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
22/05 SMS Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
22/05 SMS Pharmaceuticals March-quarter consol net profit 327.1 million rupees
22/05 SMS Pharmaceuticals Limited Approves the Shifting of Registered Office
22/05 SMS Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2025 - 2026
29/04 Sms Pharmaceuticals says tax demand reduced to 4 million rupees from 71.9 million rupees
26/02 Alert incorrectly tagged to SMS Pharmaceuticals withdrawn
09/02 SMS Pharmaceuticals Limited Reaffirms Earnings Guidance for the Fiscal Year 2026
07/02 SMS Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
26/12 Sms Peptides Private Limited announced that it has received INR 39.9 million in funding from SMS Pharmaceuticals Limited
12/12 SMS Pharmaceuticals Limited Announces Successful Completion of USFDA Inspection At Vizag Facility
26/11 SMS Pharmaceuticals Associate Company Gets US FDA Approval for Reformulated Ranitidine
26/11 SMS Pharmaceuticals says VKT Pharma receives US FDA approval for reformulated ranitidine
10/11 SMS Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2026
08/11 SMS Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
11/09/25 SMS Pharmaceuticals Raises INR476 Million via Equity Allotment; Shares Jump 11%
26/08/25 Alerts wrongly tagged to SMS Pharmaceuticals withdrawn
26/08/25 SMS Pharmaceuticals Limited Announces the Successful Closure of the Recent Inspection by the USFDA
11/08/25 SMS Pharmaceuticals Limited announces Annual dividend, payable on October 29, 2025
10/08/25 SMS Pharmaceuticals Limited Provides Financial Guidance for the Fiscal 2026
09/08/25 SMS Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
27/06/25 Sms Peptides Private Limited announced that it has received INR 30 million in funding from SMS Pharmaceuticals Limited
26/06/25 INDIA STOCKS-Indian shares extend gains on easing Mideast tensions; metals lend support
02/06/25 SMS Pharmaceuticals Limited Announces Earnings Guidance for the Year 2026
Aucun résultat pour cette recherche